UNDIFFERENTIATED SARCOMA
Clinical trials for UNDIFFERENTIATED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED SARCOMA trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on sarcoma in new combo trial
Disease control Recruiting nowThis early-stage study is testing whether a new type of immune cell therapy, called HER2-CAR T cells, combined with drugs that boost the immune system (pembrolizumab or nivolumab), is safe for people with advanced sarcoma. About 25 participants will receive chemotherapy before th…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for rare childhood cancers: drug trial targets stubborn sarcomas
Disease control Recruiting nowThis study is testing a drug called lurbinectedin in people aged 10 and older whose solid tumors (like Ewing sarcoma) have come back or not responded to standard treatment. The goal is to see if the drug is safe and can shrink tumors or delay their growth. Participants must have …
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:40 UTC